TYK Medicines, Inc (HKG: 2410)
Hong Kong
· Delayed Price · Currency is HKD
48.00
-1.20 (-2.44%)
Jan 3, 2025, 4:08 PM HKT
TYK Medicines Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Revenue | - | - | 44.24 |
| Cost of Revenue | - | - | 24.2 |
| Gross Profit | - | - | 20.04 |
| Selling, General & Admin | 77.23 | 59.31 | 33.54 |
| Research & Development | 267.57 | 249.25 | 229.81 |
| Operating Expenses | 344.8 | 308.56 | 263.35 |
| Operating Income | -344.8 | -308.56 | -243.31 |
| Interest Expense | -9.68 | -8.73 | -3.26 |
| Interest & Investment Income | 2.03 | 3.73 | 7.37 |
| Currency Exchange Gain (Loss) | -0.06 | 0.1 | - |
| Other Non Operating Income (Expenses) | -76.35 | -68.98 | -72.87 |
| EBT Excluding Unusual Items | -428.87 | -382.44 | -312.06 |
| Gain (Loss) on Sale of Investments | 0.01 | -0.73 | 0.34 |
| Gain (Loss) on Sale of Assets | -0.01 | -0.01 | -0.04 |
| Other Unusual Items | 0.01 | 0.01 | -0.05 |
| Pretax Income | -428.86 | -383.17 | -311.8 |
| Earnings From Continuing Operations | -428.86 | -383.17 | -311.8 |
| Minority Interest in Earnings | 0.91 | 0.74 | 0.81 |
| Net Income | -427.94 | -382.43 | -310.99 |
| Net Income to Common | -427.94 | -382.43 | -310.99 |
| Shares Outstanding (Basic) | 305 | 289 | 278 |
| Shares Outstanding (Diluted) | 305 | 289 | 278 |
| Shares Change (YoY) | - | 3.94% | - |
| EPS (Basic) | -1.40 | -1.32 | -1.12 |
| EPS (Diluted) | -1.40 | -1.32 | -1.12 |
| Free Cash Flow | -278.3 | -277.32 | -279.02 |
| Free Cash Flow Per Share | -0.91 | -0.96 | -1.00 |
| Gross Margin | - | - | 45.30% |
| Operating Margin | - | - | -549.94% |
| Profit Margin | - | - | -702.94% |
| Free Cash Flow Margin | - | - | -630.67% |
| EBITDA | -330.28 | -295.1 | -232.31 |
| D&A For EBITDA | 14.52 | 13.46 | 11 |
| EBIT | -344.8 | -308.56 | -243.31 |
Source: S&P Capital IQ. Standard template.
Financial Sources.